Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells-Reference-Cited by-同舟云学术

Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells

Published:2015-09-02 Issue:9 Volume:10 Page:e0137664
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gao Wei,Kim Heungnam,Ho Mitchell

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma;N Akutsu;World J Gastroenterol,2010

2. From minimal to maximal surgery in the treatment of hepatocarcinoma: A review;MV Perini;World J Hepatol,2015

3. Hepatocellular carcinoma: clinical frontiers and perspectives;J Bruix;Gut,2014

4. Functions of cell surface heparan sulfate proteoglycans;M Bernfield;Annu Rev Biochem,1999

5. Roles of heparan-sulphate glycosaminoglycans in cancer;R Sasisekharan;Nat Rev Cancer,2002

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation;American Journal of Cancer Research;2024

2. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma;Frontiers in Immunology;2023-12-19

3. Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients;International Journal of Molecular Sciences;2023-06-30

4. Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis;Cancer Research;2023-04-07

5. Glypicans, 35 years later;Proteoglycan Research;2023-04